XML 39 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Note 10 - Net Loss Per Share of Common Stock
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Earnings Per Share [Text Block]
NOTE
10
: NET LOSS PER SHARE OF COMMON STOCK
 
Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period, plus dilutive potential shares of common stock considered outstanding during the period, in accordance with FASB ASC
No.
260,
“Earnings Per Share.”
 
   
Nine months ended

September 30,
   
Three months ended

September 30,
 
   
2019
(unaudited)
   
2018
(unaudited)
   
2019
(unaudited)
   
2018
(unaudited)
 
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
  $
(3,034
)   $
(1,729
)   $
775
    $
2,543
 
Denominator (in thousands):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic weighted-average common stock outstanding
   
21,936
     
22,091
     
21,953
     
21,997
 
Effect of stock -based awards
   
     
     
451
     
431
 
Diluted weighted average common stock outstanding
   
21,936
     
22,091
     
22,404
     
22,428
 
                                 
Basic net income (loss) per share
  $
(0.14
)   $
(0.08
)   $
0.04
    $
0.12
 
Diluted net income (loss) per share
  $
(0.14
)   $
(0.08
)   $
0.03
    $
0.11
 
 
 
The weighted average number of shares related to outstanding equity-based awards excluded from the calculation of diluted net income per share, since their effect was anti-dilutive, was
105,901
shares for the
three
months ended
September 30, 2019.
The total number of shares related to the outstanding equity-based awards excluded from the calculation of diluted net loss per share was
1,385,525
for the
nine
months ended
September 30, 2019.
The weighted average number of shares related to outstanding equity-based awards excluded from the calculation of diluted net income per share, since their effect was anti-dilutive, was
136,113
shares for the
three
months ended
September 30, 2018.
The total number of shares related to the outstanding equity-based awards excluded from the calculation of diluted net loss per share was
1,273,610
for the
nine
months ended
September 30, 2018.